Revolution Medicines, Dividends

RVMDW Stock   0.33  0.01  3.09%   
Dividend Paid And Capex Coverage Ratio is likely to drop to -47.63 in 2024. Revolution Medicines,'s past performance could be the main factor of why investors trade Revolution Medicines, Warrant stock today. Investors should clearly understand every aspect of the Revolution Medicines, dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Revolution Medicines,'s dividend schedule and payout information. Revolution Medicines, Warrant dividends can also provide a clue to the current valuation of Revolution Medicines,.
Last ReportedProjected for Next Year
Dividend Paid And Capex Coverage Ratio(45.36)(47.63)
One of the primary advantages of investing in dividend-paying companies such as Revolution Medicines, is that dividends usually grow steadily over time. As a result, well-established companies that pay dividends typically increase their dividend payouts yearly, which many long-term traders find attractive.

Revolution Medicines, Quarterly Total Cash From Financing Activities

77.29 Million

  
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Revolution Medicines, must own a stock before its ex-dividend date to receive its next dividend.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Revolution Medicines,. If investors know Revolution will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Revolution Medicines, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
0.005
Return On Assets
(0.29)
Return On Equity
(0.47)
The market value of Revolution Medicines, is measured differently than its book value, which is the value of Revolution that is recorded on the company's balance sheet. Investors also form their own opinion of Revolution Medicines,'s value that differs from its market value or its book value, called intrinsic value, which is Revolution Medicines,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Revolution Medicines,'s market value can be influenced by many factors that don't directly affect Revolution Medicines,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Revolution Medicines,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Revolution Medicines, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Revolution Medicines,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Compare Dividends Across Peers

Specify up to 10 symbols: